TITLE 77: PUBLIC HEALTH
CHAPTER I: DEPARTMENT OF PUBLIC HEALTH SUBCHAPTER k: COMMUNICABLE DISEASE CONTROL AND IMMUNIZATIONS
PART 690
CONTROL OF COMMUNICABLE DISEASES CODE
SECTION 690.100 DISEASES AND CONDITIONS
Section 690.100 Diseases and
Conditions
The following diseases and
conditions are declared to be contagious, infectious or communicable and may be
dangerous to the public health. Each suspected or diagnosed case shall be
reported to the local health authority, which shall subsequently report each
case to the Department. The method of reporting shall be as described in the
individual Section for the reportable disease.
a) Class I(a)
The following diseases shall be
reported immediately (within three hours) by telephone, upon initial clinical
suspicion of the disease, to the local health authority, which shall then
report to the Department immediately (within three hours). This interval
applies to primary reporters identified in Section 690.200(a)(1) who are
required to report to local health authorities and to local health authorities
that are required to report to the Department. The Section number associated
with each of the listed diseases indicates the Section under which the diseases
are reportable. Laboratory specimens of agents required to be submitted under
Subpart D shall be submitted within 24 hours to the Department laboratory.
1)
|
Any unusual case of a disease
or condition caused by an infectious agent not listed in this Part that is of
urgent public health significance
|
690.295
|
|
|
|
2)
|
Anthrax*
|
690.320
|
|
|
|
3)
|
Botulism, foodborne
|
690.327
|
|
|
|
4)
|
Brucellosis* (if suspected to
be a bioterrorist event or part of an outbreak)
|
690.330
|
|
|
|
5)
|
Coronavirus, Novel, including
Coronavirus Disease 19 (COVID-19), Severe Acute Respiratory Syndrome (SARS),
and Middle Eastern Respiratory Syndrome (MERS)
|
690.361
|
|
|
|
6)
|
Diphtheria
|
690.380
|
|
|
|
7)
|
Influenza A, Novel Virus
|
690.469
|
|
|
|
8)
|
Plague*
|
690.570
|
|
|
|
9)
|
Poliomyelitis
|
890.580
|
|
|
|
10)
|
Q-fever* (if suspected to be a
bioterrorist event or part of an outbreak)
|
690.595
|
|
|
|
11)
|
Smallpox
|
690.650
|
|
|
|
12)
|
Tularemia*
(if suspected to be a bioterrorist event or part of
an outbreak)
|
690.725
|
|
|
|
13)
|
Any
suspected bioterrorist threat or event
|
690.800
|
|
|
|
|
b) Class I(b)
The following
diseases shall be reported as soon as possible during normal business hours,
but within 24 hours (i.e., within eight regularly scheduled business hours
after identifying the case), to the local health authority, which shall then
report to the Department as soon as possible, but within 24 hours. This
interval applies to primary reporters identified in Section 690.200(a)(1) who
are required to report to local health authorities and to local health
authorities that are required to report to the Department. The Section number
associated with each of the listed diseases indicates the Section under which
the diseases are reportable. Laboratory specimens of agents required to be
submitted under Subpart D shall be submitted within 7 days after identification
of the organism to the Department laboratory.
1)
|
Botulism, intestinal, wound,
and other
|
690.327
|
|
|
|
2)
|
Brucellosis* (if not suspected to be a bioterrorist event
or part of an outbreak)
|
690.330
|
|
|
|
3)
|
Chickenpox (Varicella)
|
690.350
|
|
|
|
4)
|
Cholera*
|
690.360
|
|
|
|
5)
|
Escherichia coli infections*
(E. coli O157:H7 and other Shiga toxin-producing E. coli)
|
690.400
|
|
|
|
6)
|
Haemophilus influenzae,
meningitis and other invasive disease*
|
690.441
|
|
|
|
7)
|
Hantavirus pulmonary syndrome*
|
690.442
|
|
|
|
8)
|
Hemolytic uremic syndrome,
post-diarrheal
|
690.444
|
|
|
|
9)
|
Hepatitis A
|
690.450
|
|
|
|
10)
|
Influenza admissions into
intensive care unit
|
690.468
|
|
|
|
11)
|
Measles
|
690.520
|
|
|
|
12)
|
Mumps
|
690.520
|
|
|
|
13)
|
Neisseria meningitidis, meningitis
and invasive disease*
|
690.555
|
|
|
|
14)
|
Outbreaks of public health
significance (including, but not limited to, foodborne and waterborne
outbreaks)
|
690.565
|
|
|
|
15)
|
Pertussis* (whooping cough)
|
690.750
|
|
|
|
16)
|
Q-fever due to Coxiella
burnetii* (if not suspected to be a bioterrorist event or part of an
outbreak)
|
690.595
|
|
|
|
17)
|
Rabies, human
|
690.600
|
|
|
|
18)
|
Rabies, potential human
exposure and animal rabies
|
690.601
|
|
|
|
19)
|
Rubella
|
690.620
|
|
|
|
20)
|
Smallpox vaccination,
complications of
|
690.655
|
|
|
|
21)
|
Staphylococcus aureus
infections with intermediate or high level resistance to Vancomycin*
|
690.661
|
|
|
|
22)
|
Streptococcal infections,
Group A, invasive and sequelae to Group A streptococcal infections
|
690.670
|
|
|
|
23)
|
Tularemia* (if not suspected to be a bioterrorist event
or part of an outbreak)
|
690.725
|
|
|
|
24)
|
Typhoid fever*
|
690.730
|
|
|
|
25)
|
Typhus
|
690.740
|
c) Class II
The following
diseases shall be reported as soon as possible during normal business hours,
but within seven days, to the local health authority, which shall then report
to the Department within seven days. The Section number associated with each
of the listed diseases indicates the Section under which the diseases are
reportable. Laboratory specimens of agents required to be submitted under
Subpart D shall be submitted within seven days after identification of the
organism to the Department laboratory.
1)
|
Arboviral Infection*
(including, but not limited to, Chikungunya fever, California encephalitis,
Dengue fever, St. Louis encephalitis and West Nile virus)
|
690.322
|
|
|
|
2)
|
Campylobacteriosis
|
690.335
|
|
|
|
3)
|
Cryptosporidiosis
|
690.365
|
|
|
|
4)
|
Cyclosporiasis
|
690.368
|
|
|
|
5)
|
Hepatitis B and Hepatitis D
|
690.451
|
|
|
|
6)
|
Hepatitis C
|
690.452
|
|
|
|
7)
|
Histoplasmosis
|
690.460
|
|
|
|
8)
|
Influenza, deaths in persons
less than 18 years of age
|
690.465
|
|
|
|
9)
|
Legionellosis*
|
690.475
|
|
|
|
10)
|
Leptospirosis*
|
690.490
|
|
|
|
11)
|
Listeriosis*
|
690.495
|
|
|
|
12)
|
Malaria*
|
690.510
|
|
|
|
13)
|
Psittacosis due to Chlamydia
psittaci
|
690.590
|
|
|
|
14)
|
Salmonellosis* (other than
typhoid fever)
|
690.630
|
|
|
|
15)
|
Shigellosis*
|
690.640
|
|
|
|
16)
|
Toxic shock syndrome due to
Staphylococcus aureus infection
|
690.695
|
|
|
|
17)
|
Streptococcus pneumoniae,
invasive disease in children less than five years
|
690.678
|
|
|
|
18)
|
Tetanus
|
690.690
|
|
|
|
19)
|
Tickborne Disease, including Babesiosis,
Ehrlichiosis, Anaplasmosis, Lyme disease, and Spotted Fever Rickettsiosis
|
690.698
|
|
|
|
20)
|
Trichinosis
|
690.710
|
|
|
|
21)
|
Vibriosis (Other than
Toxigenic Vibrio cholera O1 or O139)
|
690.745
|
* Diseases for
which laboratories are required to forward clinical materials to the Department's
laboratory.
d) When an epidemic of a disease dangerous to the public health
occurs, and present rules are not adequate for its control or prevention, the
Department shall issue more stringent requirements.
(Source: Amended at 44 Ill.
Reg. 20145, effective December 9, 2020)
|